Deficiency of Interleukin-1 Receptor Antagonist Promotes Neointimal Formation After Injury
Open accessThe DOI matches its Crossref record; 2 of the 2 references it cites were found in a registry or an index.
Abstract
Background— The cytokine interleukin (IL)-1 is an important mediator of inflammation and cardiovascular disease. Activity of this cytokine is modulated endogenously via the IL-1 receptor antagonist (IL-1Ra). The role of IL-1Ra in neointima formation after injury, however, is poorly understood. Methods and Results— Using IL-1Ra–deficient (IL-1Ra −/− ; backcrossed 8 generations into the C57BL/6J background) and wild-type (IL-1Ra +/+ ) mice, we investigated neointimal formation 3 weeks after femoral artery injury induced by an external vascular cuff model. Intima and media thicknesses were measured, and the intima/media ratio was calculated. The mean intimal thickness and the intima/media ratio of IL-1Ra −/− mice increased by 249% (31.8±2.9 μm [n=10] versus 9.1±0.7 μm [n=10]; P <0.0001) and 257% (2.5±0.2 versus 0.7±0.1; P <0.0001), respectively, compared with IL-1Ra +/+ mice. No significant differences were observed in the medial thickness. Control immunostaining for IL-1Ra in injured vessels localized IL-1β and the endogenous inhibitor in the endothelium and inflammatory cells of the adventitia in IL-1Ra +/+ but not IL-1Ra −/− mice. Conclusions— The absence of IL-1Ra promotes neointimal formation in mice after injury. These results suggest that endogenous IL-1Ra may suppress other occlusive vascular responses to injury, such as atherosclerosis and restenosis after angioplasty.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Biologic basis for interleukin-1 in disease.
Dinarello, C. (1996) · Blood · doi:10.1182/blood.v87.6.2095.bloodjournal8762095 · Cited by 4,344
Horai, R., Asano, M., Sudo, K., Kanuka, H., Suzuki, M., Nishihara, M., Takahashi, M., & Iwakura, Y. (1998) · The Journal of Experimental Medicine · doi:10.1084/jem.187.9.1463 · Cited by 611
Self-citation
Cited by
Ridker, P. M., Thuren, T., Zalewski, A., & Libby, P. (2011) · American Heart Journal · doi:10.1016/j.ahj.2011.06.012 · Cited by 799
Cytokines in atherosclerosis: Key players in all stages of disease and promising therapeutic targets
Ramji, D. P., & Davies, T. S. (2015) · Cytokine & Growth Factor Reviews · doi:10.1016/j.cytogfr.2015.04.003 · Cited by 469
Cheung, C., Bernardo, A. S., Trotter, M. W. B., Pedersen, R. A., & Sinha, S. (2012) · Nature Biotechnology · doi:10.1038/nbt.2107 · Cited by 397
van der Heijden, T., Kritikou, E., Venema, W., van Duijn, J., van Santbrink, P. J., Slütter, B., Foks, A. C., Bot, I., & Kuiper, J. (2017) · Arteriosclerosis, Thrombosis, and Vascular Biology · doi:10.1161/atvbaha.117.309575 · Cited by 348
“Also, deficiency of IL-1RA (interleukin-1 receptor antagonist) in apoE mice resulted in highly increased expression of ICAM-1, VCAM-1, and MCP-1 in the aorta.(16) In line with these data, we observe that inhibition of the NLRP3 inflammasome by MCC950, and thereby IL-1β secretion, reduces both VCAM-1 and ICAM-1 mRNA”
Adipose tissue: a regulator of inflammation
Juge-Aubry, C. E., Henrichot, E., & Meier, C. A. (2005) · Best Practice & Research Clinical Endocrinology & Metabolism · doi:10.1016/j.beem.2005.07.009 · Cited by 347
Metadata
- Authors
- Isoda, K., Shiigai, M., Ishigami, N., Matsuki, T., Horai, R., Nishikawa, K., Kusuhara, M., Nishida, Y., Iwakura, Y., & Ohsuzu, F.
- Venue
- Circulation
- Published
- 2003-08-05
- Volume
- 108
- Issue
- 5
- Pages
- 516-518
- ISSN
- 0009-7322 (ISSN-L)
- 1524-4539
- OpenAlex
- W2024051610
- Cited by
- 107
- References
- 2
- FWCI
- 1.87
- Type
- journal article
- Language
- en
- Open access
- hybrid
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Deficiency of Interleukin-1 Receptor Antagonist Promotes Neointimal Formation After Injury. https://app.cochat.ai/papers/10.1161/01.cir.0000085567.18648.21
- The paper
- Isoda, K., Shiigai, M., Ishigami, N., Matsuki, T., Horai, R., Nishikawa, K., Kusuhara, M., Nishida, Y., Iwakura, Y., & Ohsuzu, F. (2003). Deficiency of Interleukin-1 Receptor Antagonist Promotes Neointimal Formation After Injury. Circulation. https://doi.org/10.1161/01.cir.0000085567.18648.21
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.